Showing results (81-90 of 111) with videos related to
Sort By:
Pageof 12
Cancer Letters|January 23, 2016
CD24 suppresses malignant phenotype by downregulation of SHH transcription through STAT1 inhibition in breast cancer cellsKumi Suyama, Hideya Onishi, Akira Imaizumi, et al.Oncology Reports|March 2, 2021
GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancerShu Ichimiya, Hideya Onishi, Shinjiro Nagao, et al.Anticancer Research|December 3, 2024
A Novel Oncolytic Viral Therapy Using Coxsackievirus B3 (CVB3) for Human Pancreatic Cancer Including Cancer-associated FibroblastsHisanobu Ogata, Akira Imaizumi, Yutaka Fujioka, et al.Cancer Immunology, Immunotherapy : CII|October 29, 2009
Nuclear factor kappaB-activated monocytes contribute to pancreatic cancer progression through the production of ShhAkio Yamasaki, Chizu Kameda, Rui Xu, et al.Anticancer Research|July 20, 2021
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic CancerYasuhiro Oyama, Shinjiro Nagao, Lin Na, et al.Scientific Reports|November 10, 2023
Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2Noritaka Komune, Kuniaki Sato, Mayumi Ono, et al.Journal of Cancer Research and Clinical Oncology|August 16, 2023
PTPN3 inhibition contributes to the activation of the dendritic cell function to be a promising new immunotherapy targetNaoya Iwamoto, Hideya Onishi, Shogo Masuda, et al.Human Cell|May 19, 2004
Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectivesTakashi Morisaki, Kotaro Matsumoto, Hideya Onishi, et al.Anticancer Research|March 27, 2026
Gene Therapy for Malignant Tumors: Focused on Immunostimulatory Oncolytic Coxsackievirus A11 (CVA11)Hisanobu Ogata, Haruki Nagano, Yutaka Fujioka, et al.Anticancer Research|May 31, 2022
PTPN3 Could Βe a Therapeutic Target of Pancreatic CancerHideya Onishi, Naoya Iwamoto, Keita Sakanashi, et al.Pageof 12